ResMed | RMD

ResMed traded at $210.67 this Monday March 20th, increasing $3.57 or 1.72 percent since the previous trading session. Looking back, over the last four weeks, ResMed gained 2.14 percent. Over the last 12 months, its price fell by 18.01 percent. Looking ahead, we forecast ResMed to be priced at 200.51 by the end of this quarter and at 181.99 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
210.67
Daily Change
1.72%
Yearly
-18.01%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Ansell 26.40 0.26 0.99% 6.02%
AtriCure 39.02 -0.18 -0.46% -39.50%
Baxter International 38.18 0.60 1.58% -51.71%
Cochlear 225.32 -3.63 -1.59% 0.72%
Cooper Companies 345.00 3.50 1.02% -17.48%
Artivion Inc 12.09 0.28 2.33% -42.07%
Cardiovascular Systems 19.74 -0.02 -0.10% -3.38%
CSL 284.90 -2.36 -0.82% 6.72%
Dexcom 117.23 3.30 2.90% 1.86%
Estia Health 2.16 0 0% -2.70%
Edwards Lifesciences 81.03 0.29 0.36% -27.36%
Fisher Paykel Healthcare 24.88 -0.18 -0.72% -10.92%
Globus Medical 52.45 0.62 1.20% -23.51%
Haemonetics 78.42 1.81 2.36% 41.04%
Hologic 78.36 1.29 1.67% 3.38%
Integra LifeSciences 54.03 0.59 1.10% -16.34%
Idexx Laboratories 482.74 11.38 2.41% -10.54%
Inogen 12.71 0.05 0.39% -62.01%
Intuitive Surgical 240.51 2.71 1.14% -15.10%
Invacare 0.02 0.01 34.12% -98.57%
Masimo 174.72 2.99 1.74% 10.49%
Medtronic 79.61 1.32 1.69% -26.80%
NuVasive 37.31 0.48 1.30% -27.86%
Philips 14.92 -0.51 -3.33% -46.74%
Insulet 318.30 9.21 2.98% 25.61%
Ramsay Health Care 64.44 -1.23 -1.87% 1.82%
ResMed 210.67 3.57 1.72% -18.01%
Sonic Healthcare 33.82 -0.04 -0.12% -3.54%
Sigma Healthcare Ltd 0.64 -0.01 -0.78% 15.45%
Smith Nephew 28.52 0.20 0.71% -13.21%
Steris 181.26 4.70 2.66% -22.52%
Teleflex 237.32 1.48 0.63% -31.94%
Thermo Fisher Scientific 550.57 3.23 0.59% -6.57%

Indexes Price Day Year
US400 2414 39.57 1.67% -10.47%
US500 3955 34.93 0.89% -11.35%

ResMed
ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep apnea, chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.